Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
138.89
-6.24 (-4.30%)
At close: Aug 24, 2026, 4:00 PM EDT
139.17
+0.28 (0.20%)
After-hours: Aug 24, 2026, 6:46 PM EDT
Moderna Stock Forecast
Stock Price Forecast
According to 23 analysts polled by S&P Global, Moderna stock has a consensus rating of "Hold" and an average price target of $95.67. The average 1-year stock price forecast is 31.12% lower than the current stock price, while the lowest is $25 (-82.00%) and the highest is $170 (+22.40%).
Price Target: $95.67 (-31.12%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 2 | 2 | 2 | 1 | 2 | 1 |
| Hold | 17 | 16 | 16 | 17 | 16 | 17 |
| Sell | 2 | 2 | 3 | 3 | 2 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 24 | 23 | 24 | 24 | 23 | 23 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Hold Maintains $48 → $125 | Hold | Maintains | $48 → $125 | -10.00% | Aug 24, 2026 |
| UBS | UBS | Hold Maintains $50 → $150 | Hold | Maintains | $50 → $150 | +8.00% | Aug 20, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $39 → $89 | Hold | Maintains | $39 → $89 | -35.92% | Aug 19, 2026 |
| Jefferies | Jefferies | Hold Reiterates $60 | Hold | Reiterates | $60 | -56.80% | Aug 19, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Upgrades $40 → $170 | Hold | Upgrades | $40 → $170 | +22.40% | Aug 19, 2026 |
Financial Forecast
Revenue This Year
2.11B
from 1.94B
Increased by 8.35%
Revenue Next Year
2.46B
from 2.11B
Increased by 16.66%
EPS This Year
-8.62
from -7.26
EPS Next Year
-4.58
from -8.62
EPS and Forward PE are based on non-GAAP adjusted numbers.